Prevalence of High-Grade Prostatic Intraepithelial Neoplasia in Prostate Gland of Korean Men: Comparisons Between Radical Prostatectomy and Cystoprostatectomy

Urology ◽  
2007 ◽  
Vol 70 (6) ◽  
pp. 1100-1103 ◽  
Author(s):  
Kyung Seok Han ◽  
In Gab Jeong ◽  
Jea Young Joung ◽  
Seung Ok Yang ◽  
Jinsoo Chung ◽  
...  
2007 ◽  
Vol 0 (0) ◽  
pp. 070907021207002-???
Author(s):  
Phillip M. Pierorazio ◽  
Sarah M. Lambert ◽  
Mahesh Matsukhani ◽  
Preston C. Sprenkle ◽  
Tara R. McCann ◽  
...  

Medicina ◽  
2010 ◽  
Vol 46 (9) ◽  
pp. 604 ◽  
Author(s):  
Stasys Auškalnis ◽  
Daimantas Milonas ◽  
Mindaugas Jievaltas ◽  
Kęstutis Vaičiūnas ◽  
Antanas Mickevičius ◽  
...  

The objective of the study was to evaluate the relationship between high-grade intraepithelial neoplasia diagnosed after radical retropubic prostatectomy and the clinical and pathological characteristics of prostate cancer, and to evaluate the time to biochemical relapse of the disease within the groups of high-grade prostatic intraepithelial neoplasia (HGPIN) and non-HGPIN patients. Material and methods. Patients, clinically diagnosed with local prostate carcinoma at the Clinic of Urology, Kaunas University of Medicine, during 2003–2007 and treated with radical retropubic prostatectomies, were distributed into two groups according to the HGPIN detected in the postoperative material: HGPIN and non-HGPIN. The two groups were compared in terms of preoperative and postoperative characteristics. The patients who were followed up for at least 12 months were included into the study. The biochemical relapse of prostate cancer was determined if there were two consecutive rises of prostate-specific antigen (PSA) level above 0.2 ng/mL or according to the attending physician’s opinion, there was a need for adjuvant treatment even with onetime rise of PSA level above 0.2 ng/mL. Results. There was no significant difference between the HGPIN and non-HGPIN groups in terms of time to biochemical relapse and frequency of biochemical relapses, time before surgery, the timing of the HGPIN diagnosis, age, or PSA level. After radical prostatectomy, patients in the HGPIN group were found to have significantly more often poorer cancer cell differentiation according to the Gleason score (≥7 vs. <7; P=0.001) and higher TNM stage (T3a,b vs. T2a,b,c; P=0.001). Fewer positive resection margins were diagnosed in the HGPIN group (P=0.05). The groups did not differ in terms of the degree of differentiation according to the Gleason score or perineural invasion (P=0.811 and P=0.282, respectively). Conclusions. HGPIN was more often associated with the characteristics of the poor prognosis for relapse of prostate cancer: poorer tumor cell differentiation according to the Gleason score and more cases of higher TNM stage. HGPIN did not have any influence on biochemical relapse of the disease during the short-term follow-up.


2007 ◽  
Vol 131 (7) ◽  
pp. 1122-1125 ◽  
Author(s):  
Ronald J. Cohen ◽  
Beverly A. Shannon ◽  
Sydney L. Weinstein

Abstract Intraductal carcinoma of the prostate (IDC-P) gland represents an intraluminal neoplastic proliferation that is distinct from high-grade prostatic intraepithelial neoplasia (HG-PIN) and almost always coexists with large-volume, high-stage, and high-grade invasive carcinoma. We document an unusual presentation of apparently “early” IDC-P without an aggressive invasive element that, despite being confined to the acinar-ductal system, has gained access to the ejaculatory duct and seminal vesicle by transmucosal spread. This finding confirms that IDC-P, in contrast to HG-PIN, is inherently aggressive and has the ability to spread beyond the prostate gland. In this case, the absence of an aggressive invasive element suggests that IDC-P has most likely evolved within the lumens directly from HG-PIN.


2014 ◽  
Vol 92 (3) ◽  
pp. 264-269 ◽  
Author(s):  
Alexandre Ingels ◽  
Guillaume Ploussard ◽  
Yves Allory ◽  
Claude Abbou ◽  
Alexandre de la Taille ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document